High Costs Block Sick Patients from Medical Cannabis – Scrolla.Africa
Medical cannabis pricing barriers significantly limit patient access to regulated treatments. High costs drive some patients toward unregulated products, risking safety and efficacy. Addressing these barriers is crucial for equitable healthcare.
Too Many Slick Sellers Take Bloom Off Medicinal Cannabis
Commercial pressure medicinal cannabis creates clinical challenges by influencing patient expectations and product choices. Marketing tactics can mislead patients about efficacy and safety. This article highlights the need for evidence-based cannabis…
Smoke Alarm: Is Colorado’s Cannabis Industry Burning Out? – Denver Westword
The colorado cannabis industry decline is raising concerns about patient access to consistent, quality-controlled cannabis products. Market consolidation and regulatory challenges are impacting local dispensaries and product variety. Patients and…
“Above and beyond”: Calls to further reduce restrictions on medicinal cannabis industry
Medicinal cannabis licensing is under review with calls to reduce restrictions that limit patient access and industry development. Regulatory changes aim to streamline licensing and improve product availability. These updates are critical for clinicians…
Is Florida’s Medical Cannabis Market Dominance the Key Factor?
Florida medical cannabis market dominance is shaping patient access and product availability. Trulieve cannabis stock reflects this market consolidation trend. Understanding these dynamics is crucial for patients and clinicians alike.
CannaLnx Expands Insured Medical Cannabis Access in California With 9 Retail, Delivery Partners
Insurance coverage medical cannabis is expanding in California through CannaLnx's new partnerships with retail and delivery providers. This development reduces barriers for patients relying on cannabis therapies. Improved insurance access may enhance…
Welsh Lib Dems pass motion to protect medical cannabis patients – leafie
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyAccessMedical CannabisHealthcare…
Dispensary Warehouse Group Launches $2M Capital Raise to Scale SOVRYN, Australia’s …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Healthcare…
Commercial Insurance Has Failed Cannabis. Here’s What’s Next
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic AccessHealthcare PolicyInsurancePatient…
MMJ International Holdings Seeks Injunction to Halt CMS CBD Program
Legal challenges institutional CBD programs can disrupt patient access and create uncertainty for clinicians. MMJ International Holdings seeks an injunction to halt the CMS CBD program. Understanding these challenges helps providers prepare contingency…
